# Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis

> **NCT05493124** · EARLY_PHASE1 · UNKNOWN · sponsor: **Beijing University of Chinese Medicine** · enrollment: 180 (estimated)

## Conditions studied

- Chronic Atrophic Gastritis

## Interventions

- **DRUG:** Manpixiao
- **DRUG:** Active comparator

## Key facts

- **NCT ID:** NCT05493124
- **Lead sponsor:** Beijing University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05493124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05493124, "Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05493124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*